A Senate investigations subcommittee has released a report concluding that federal health agencies withheld critical information about the risks of myocarditis following mRNA COVID-19 vaccination.
Sen. Ron Johnson (R-WI), chairman of the Senate Permanent Subcommittee on Investigations, presented the panel’s findings on Wednesday. The report revealed that the Biden administration was aware of the potential risks associated with mRNA vaccines and acknowledged significant gaps in data collection. However, the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and other federal health agencies reportedly made deliberate efforts to downplay and delay informing the public about the risks of adverse heart conditions linked to the Pfizer and Moderna mRNA vaccines, lawmakers concluded.
This revelation has reignited discussions about myocarditis, chronic inflammation, and the need for public health transparency. As concerns over myocarditis, particularly among young individuals vaccinated with mRNA vaccines, continue to grow, renowned neurosurgeon and former Secretary of Housing and Urban Development, Dr. Ben Carson, announced the development of a groundbreaking natural therapy designed to address lingering symptoms associated with myocarditis and chronic inflammation linked to long COVID and other conditions. Dr. Carson, who has shifted his focus to medical research after his tenure in public service, stated that this innovative therapy leverages scientifically validated natural compounds to reduce inflammation, regulate immune system responses, and support recovery from persistent health issues.
“Myocarditis and chronic inflammation have become pressing public health concerns, particularly in light of the recent findings regarding vaccine-related adverse events,” Dr. Carson said during a press briefing on Wednesday. “This therapy represents hope for thousands of individuals experiencing ongoing symptoms of myocarditis or systemic inflammation, whether triggered by vaccination, viral infections, or other causes. In times like these, it is essential that we prioritize solutions that restore both health and public trust.”
Dr. Carson’s natural therapy combines Curcumin, Omega-3 fatty acids, Coenzyme Q10 (CoQ10), Vitamin D, and Piperine (Black Pepper Extract), all of which have been scientifically shown to reduce inflammation and support cardiovascular and immune health. The therapy is designed to help manage a wide range of symptoms associated with myocarditis and chronic inflammation, including:
● Chest pain or discomfort: A hallmark symptom of myocarditis, often accompanied by heart palpitations.
● Shortness of breath: Particularly during physical activity or even mild exertion.
● Irregular heartbeat: Such as heart palpitations, tachycardia, or arrhythmias.
● Persistent fatigue: A common complaint among individuals with myocarditis, post-vaccine symptoms, or long COVID.
● Muscle and joint pain: Resulting from systemic inflammation.
● Brain fog and headaches: Frequently reported by individuals with chronic inflammation or post-viral conditions.
● Sleep disturbances: Including insomnia and poor sleep quality, which exacerbate other symptoms.
The therapy has shown promising results in improving quality of life by addressing inflammation-related symptoms in initial clinical evaluations. Dr. Carson emphasized that the treatment is not intended to directly cure myocarditis or severe heart conditions but is instead designed to help mitigate symptoms and promote recovery from chronic inflammatory conditions.
CLICK HERE TO GET YOUR LATEST MEDICATION TO RELIEVE THE AFTER-EFFECTS OF COVID
The Senate report further highlights the seriousness of myocarditis, noting that cases were significantly underreported due to systemic issues with the Vaccine Adverse Event Reporting System (VAERS). Internal CDC documents revealed concerns about underreporting, with officials noting that “providers aren’t reporting these cases to VAERS.” Despite recognizing the growing risk of myocarditis, U.S. health officials delayed issuing critical alerts and guidance that could have informed healthcare providers and the public about the risks and appropriate precautions.
For example, during a February 2021 Vaccine Safety Technical Work Group meeting, CDC and FDA officials reviewed data from Israel that highlighted “a significant number of myocarditis cases, particularly in young people,” which were consistent with signals observed in U.S. data systems. However, rather than issuing a Health Alert Network (HAN) notification to warn healthcare providers and the public, officials chose to delay the release of guidance, reportedly removing precautionary language from public messaging. Drafts of CDC recommendations originally included warnings that individuals diagnosed with myocarditis should avoid strenuous physical activity—such as competitive sports—for three months during recovery, but this guidance was ultimately omitted from final public communications.
Dr. Carson criticized these delays, stating, “Transparency must be the foundation of public health. Failure to fully inform the public about risks not only erodes trust but also delays effective symptom management. This is why I felt compelled to focus my efforts on developing actionable solutions, like this natural therapy, to address the growing concerns around chronic inflammation and lingering health issues.”
The Senate report also acknowledged the groundbreaking nature of mRNA vaccine technology, which was heralded as revolutionary during the COVID-19 pandemic for its ability to prevent severe illness and death. However, the report called attention to insufficient data collection and a lack of transparency regarding rare but serious adverse events, such as myocarditis. Public health officials, including former Director of the National Institute of Allergy and Infectious Diseases Dr. Anthony Fauci, consistently emphasized the safety and efficacy of the vaccines, often downplaying concerns about rare side effects.
Dr. Carson’s newly unveiled natural therapy is expected to not only help alleviate symptoms of myocarditis and chronic inflammation but also restore public confidence in the medical community’s ability to address vaccine-related adverse events with evidence-based care. “My hope is that this therapy will serve as a beacon of progress, reassuring the public that the medical field is evolving and adapting to new challenges,” Carson said. “We must have the courage to confront difficult conversations and the determination to deliver innovative solutions.”
Amid growing calls for greater transparency and accountability from federal health agencies, Dr. Carson’s announcement highlights the importance of balancing medical advancements with public trust. His natural therapy offers a tangible step forward in addressing the lingering effects of chronic inflammation while emphasizing the critical need for openness and transparency in public health communication.
